Close Menu

restructuring

The company has scaled back its headcount from a peak of 115 employees to about 100 staff members, primarily on the commercial side.

The molecular diagnostics company has been given 60 days to demonstrate that it's in compliance with TSX listing requirements.

The moves are part of an organizational restructuring designed to increase the company's focus on its core women's health business and reduce operating costs.

A private financing fell short of its goal and the IDL joint venture has been unable to its obligations to GeneNews and Cobalt Healthcare, the owners of the JV.

The molecular diagnostics firm has retained Roth Capital Partners as financial advisor to assist in restructuring Series C Warrants issued in March.

The firm's divisions will include Sequencing Solutions, Customized Solutions, and Diagnostics Solutions.

NEW YORK (GenomeWeb) – During its fiscal third quarter, Thermo Fisher Scientific took $12.8 million in charges related to severance, the company disclosed in its Form 10-Q filed recently with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb) – Australian molecular diagnostic firm Genetic Technologies today announced a restructuring aimed at ramping up its US molecular diagnostic operations and commercializing the new version of its BrevaGen breast cancer risk test.

NEW YORK (GenomeWeb) – Saying that it does not believe its Chemical and Applied Markets division can achieve "acceptable financial performance" in the next two years, Bruker today said that it plans to sell and/or restructure certain parts of the CAM business, resulting in an expected 200 to 250

Privately held molecular diagnostics firm PrimeraDx has been forced to downsize as it undergoes a restructuring and attempts to put together a new round of financing to fund future activities, PCR Insider has learned.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.